Switch to:
More From Other Websites
The Biggest Loser: Bristol-Myers Sinks 11% Jan 20 2017
[$$] Merck Settles With Bristol-Meyers, Ono Over Cancer-Drug Patent Jan 20 2017
Biggest stock winners (including a fracking company) and losers on Donald Trump’s first day; Dow,... Jan 20 2017
Bristol-Myers lung cancer delay slams shares, keeps Merck in lead Jan 20 2017
Bristol-Myers lung cancer delay slams shares, keeps Merck in lead Jan 20 2017
Jim Cramer on Bristol-Myers' Opdivo/Yervoy Combo: 'That Story Was Taken Away From Us' Jan 20 2017
Merck, Bristol-Myers agree to settle Keytruda patent suit Jan 20 2017
Merck will pay $625 million and royalties to settle Keytruda patent litigation with Bristol-Myers... Jan 20 2017
Bristol-Myers Dives On Opdivo Setback, Will Get Keytruda Royalties Jan 20 2017
Bristol-Myers, Target Sink into Friday’s 52-Week Low Club Jan 20 2017
Bristol-Myers Squibb and Ono Pharmaceutical Company Enter Settlement and License Agreement with... Jan 20 2017
Bristol's Opdivo Dependence Now Looks Dicey Jan 20 2017
Bristol-Myers shares fall on lung cancer timeline setback Jan 20 2017
Bristol-Myers Squibb: There Goes Any Chance for Upside Jan 20 2017
Bristol-Myers shares fall on lung cancer timeline setback Jan 20 2017
Ready to Trade Bristol-Myers Squibb, Bank of America, CSX? Here's What to Know Jan 20 2017
Bristol-Myers’ tight-lipped pass on accelerated lung cancer drug approval leaves field wide open... Jan 20 2017
Stocks Up Nicely In Early Trade; Apple Shrugs Off China Trade Talk Jan 20 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK